NFE2L2 and myasthenia gravis: Nrf2 has been reported in a variety of studies about retinal injury such as hypoxia, ischemia and light damage, and an activation of NRF2 by different compounds/factors has been shown to reduce the effect of MG gliosis (Tan et al., 2015; Deliyanti et al., 2016; Inoue et al., 2017).